151 related articles for article (PubMed ID: 21773689)
1. Myeloid cells positive for CD10 at invasion front can predict poor outcome in stage II colorectal cancer.
Khanh do T; Mekata E; Mukaisho K; Shimizu T; Tatsuta T; Sugihara H; Endo Y; Kurumi Y; Tani T
Int J Clin Oncol; 2012 Jun; 17(3):240-9. PubMed ID: 21773689
[TBL] [Abstract][Full Text] [Related]
2. Prognostic role of CD10⁺ myeloid cells in association with tumor budding at the invasion front of colorectal cancer.
Khanh do T; Mekata E; Mukaisho K; Sugihara H; Shimizu T; Shiomi H; Murata S; Naka S; Yamamoto H; Endo Y; Tani T
Cancer Sci; 2011 Sep; 102(9):1724-33. PubMed ID: 21599811
[TBL] [Abstract][Full Text] [Related]
3. The Expression of CD10 and CD15 Is Progressively Increased during Colorectal Cancer Development.
Jang TJ; Park JB; Lee JI
Korean J Pathol; 2013 Aug; 47(4):340-7. PubMed ID: 24009629
[TBL] [Abstract][Full Text] [Related]
4. Transmembrane mucin MUC1 overexpression and its association with CD10⁺ myeloid cells, transforming growth factor-β1 expression, and tumor budding grade in colorectal cancer.
Khanh do T; Mekata E; Mukaisho K; Sugihara H; Shimizu T; Shiomi H; Murata S; Naka S; Yamamoto H; Endo Y; Tani T
Cancer Sci; 2013 Jul; 104(7):958-64. PubMed ID: 23566254
[TBL] [Abstract][Full Text] [Related]
5. High myeloperoxidase positive cell infiltration in colorectal cancer is an independent favorable prognostic factor.
Droeser RA; Hirt C; Eppenberger-Castori S; Zlobec I; Viehl CT; Frey DM; Nebiker CA; Rosso R; Zuber M; Amicarella F; Iezzi G; Sconocchia G; Heberer M; Lugli A; Tornillo L; Oertli D; Terracciano L; Spagnoli GC
PLoS One; 2013; 8(5):e64814. PubMed ID: 23734221
[TBL] [Abstract][Full Text] [Related]
6. Population alterations of L-arginase- and inducible nitric oxide synthase-expressed CD11b+/CD14⁻/CD15+/CD33+ myeloid-derived suppressor cells and CD8+ T lymphocytes in patients with advanced-stage non-small cell lung cancer.
Liu CY; Wang YM; Wang CL; Feng PH; Ko HW; Liu YH; Wu YC; Chu Y; Chung FT; Kuo CH; Lee KY; Lin SM; Lin HC; Wang CH; Yu CT; Kuo HP
J Cancer Res Clin Oncol; 2010 Jan; 136(1):35-45. PubMed ID: 19572148
[TBL] [Abstract][Full Text] [Related]
7. CD10 enhances metastasis of colorectal cancer by abrogating the anti-tumoural effect of methionine-enkephalin in the liver.
Kuniyasu H; Luo Y; Fujii K; Sasahira T; Moriwaka Y; Tatsumoto N; Sasaki T; Yamashita Y; Ohmori H
Gut; 2010 Mar; 59(3):348-56. PubMed ID: 19828468
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
[TBL] [Abstract][Full Text] [Related]
9. CD10 inhibits cell motility but expression is associated with advanced stage disease in colorectal cancer.
Raposo TP; Comes MS; Idowu A; Agit B; Hassall J; Fadhil W; Nica R; Ecker R; Yao T; Ilyas M
Exp Mol Pathol; 2018 Jun; 104(3):190-198. PubMed ID: 29653092
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of CD133 is a strong predictor of poor outcome in stage I colorectal cancer patients.
Reggiani Bonetti L; Migaldi M; Caredda E; Boninsegna A; Ponz De Leon M; Di Gregorio C; Barresi V; Scannone D; Danese S; Cittadini A; Sgambato A
Scand J Gastroenterol; 2012 Oct; 47(10):1211-7. PubMed ID: 22856425
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of lymphovascular invasion in stage II colorectal cancer patients with an inadequate examination of lymph nodes.
Gao Z; Cao H; Xu X; Wang Q; Wu Y; Lu Q
World J Surg Oncol; 2021 Apr; 19(1):125. PubMed ID: 33866973
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of perineural invasion in patients with stage II colorectal cancer.
Huh JW; Kim HR; Kim YJ
Ann Surg Oncol; 2010 Aug; 17(8):2066-72. PubMed ID: 20182809
[TBL] [Abstract][Full Text] [Related]
13. SPARC, FOXP3, CD8 and CD45 correlation with disease recurrence and long-term disease-free survival in colorectal cancer.
Chew A; Salama P; Robbshaw A; Klopcic B; Zeps N; Platell C; Lawrance IC
PLoS One; 2011; 6(7):e22047. PubMed ID: 21818290
[TBL] [Abstract][Full Text] [Related]
14. Identification and Construction of Combinatory Cancer Hallmark-Based Gene Signature Sets to Predict Recurrence and Chemotherapy Benefit in Stage II Colorectal Cancer.
Gao S; Tibiche C; Zou J; Zaman N; Trifiro M; O'Connor-McCourt M; Wang E
JAMA Oncol; 2016 Jan; 2(1):37-45. PubMed ID: 26502222
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of programmed cell death-ligand 1 expression and the immune microenvironment at the invasive front of colorectal cancers with high microsatellite instability.
Korehisa S; Oki E; Iimori M; Nakaji Y; Shimokawa M; Saeki H; Okano S; Oda Y; Maehara Y
Int J Cancer; 2018 Feb; 142(4):822-832. PubMed ID: 29044503
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant chemotherapy for the perineural invasion of colorectal cancer.
Suzuki T; Suwa K; Ogawa M; Eto K; Kawahara H; Fujita T; Ikegami M; Yanaga K
J Surg Res; 2015 Nov; 199(1):84-9. PubMed ID: 25935467
[TBL] [Abstract][Full Text] [Related]
17. Analysis of Spatial Organization of Suppressive Myeloid Cells and Effector T Cells in Colorectal Cancer-A Potential Tool for Discovering Prognostic Biomarkers in Clinical Research.
Zwing N; Failmezger H; Ooi CH; Hibar DP; Cañamero M; Gomes B; Gaire F; Korski K
Front Immunol; 2020; 11():550250. PubMed ID: 33193316
[TBL] [Abstract][Full Text] [Related]
18. LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer.
Stanisavljević L; Myklebust MP; Leh S; Dahl O
Acta Oncol; 2016 Dec; 55(12):1425-1433. PubMed ID: 27435662
[TBL] [Abstract][Full Text] [Related]
19. Serum CD10 is associated with liver metastasis in colorectal cancer.
Sasaki T; Kuniyasu H; Luo Y; Fujiwara R; Kitayoshi M; Tanabe E; Kato D; Shinya S; Fujii K; Ohmori H; Yamashita Y
J Surg Res; 2014 Dec; 192(2):390-4. PubMed ID: 24972738
[TBL] [Abstract][Full Text] [Related]
20. Multi-institutional study of risk factors of liver metastasis from colorectal cancer: correlation with CD10 expression.
Fujita S; Taniguchi H; Yao T; Shimoda T; Ueno H; Hirai T; Ohue M
Int J Colorectal Dis; 2010 Jun; 25(6):681-6. PubMed ID: 20204382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]